Becton, Dickinson and Company (NYSE:BDX) Q4 2023 Earnings Call Transcript
Operator: Hello, and welcome to BD's Fourth Quarter and Full Year Fiscal 2023 Earnings Call.
Stay updated with breaking news from Vaginal Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Hello, and welcome to BD's Fourth Quarter and Full Year Fiscal 2023 Earnings Call.
BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its respiratory viral panel (RVP).
Operator: Good day everyone and welcome to today’s Becton, Dickinson Q2 Fiscal Year 2023 Earnings Call. At the time, all participants are in a listen-only mode.
BD (NYSE:BDX) announced today that it received FDA 510(k) clearance for its Vaginal Panel diagnostic on the COR system.
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the outcome of a peer-reviewed...